Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | CA2 | P00918 | 3/20 | 0.51 |
| ▸ | CA9 | Q16790 | 3/20 | 0.51 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.51 |
| ▸ | CA12 | O43570 | 2/20 | 0.51 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25491825 | 0.91 | ALDH1A1 (0.61) | ALDH1A1CA2CA9PTGS2CA12 | |
| SCHEMBL5665730 | 0.90 | CYP3A4 (0.54) | ALDH1A1CA2CA9PTGS2CA12 | |
| SCHEMBL5665735 | 0.90 | CYP3A4 (0.54) | ALDH1A1CA2CA9PTGS2CA12 | |
| SCHEMBL10013522 | 0.86 | ALDH1A1 (0.59) | ALDH1A1CA2CA9PTGS2CA12 | |
| SCHEMBL30619658 | 0.86 | ALDH1A1 (0.59) | ALDH1A1CA2CA9PTGS2CA12 | |
| SCHEMBL255410 | 0.83 | ALDH1A1 (0.74) | ALDH1A1CA2CA9PTGS2CA12 | |
| SCHEMBL20186922 | 0.83 | ALDH1A1 (0.74) | ALDH1A1CA2CA9PTGS2CA12 | |
| SCHEMBL12633723 | 0.83 | ALDH1A1 (0.74) | ALDH1A1CA2CA9PTGS2CA12 | |
| SCHEMBL11588746 | 0.83 | ALDH1A1 (0.74) | ALDH1A1CA2CA9PTGS2CA12 | |
| SCHEMBL11557679 | 0.83 | ALDH1A1 (0.74) | ALDH1A1CA2CA9PTGS2CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8158135-B2 | Imine based liquid crystals for the controlled release of bioactive materials | FIRMENICH SA (CH) | 2012-04-17 | — | — | US | disclosed |
| US-20090306196-A1 | IMINE BASED LIQUID CRYSTALS FOR THE CONTROLLED RELEASE OF BIOACTIVE MATERIALS | FIRMENICH SA (CH) | 2009-12-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090306196-A1 | IMINE BASED LIQUID CRYSTALS FOR THE CONTROLLED RELEASE OF BIOACTIVE MATERIALS | BCHE, ACHE, LIPE | ALDH1A1 3124/4885CA2 714/4885CA9 482/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.